These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 6319975)

  • 1. Protein synthesis in VSV infected CNS, neuroblastoma and BHK cell lines.
    Marcovistz R; Ermine A; Tsiang H
    Microbiologica; 1983 Oct; 6(4):293-304. PubMed ID: 6319975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant replication-restricted VSV as an expression vector for murine cytokines.
    Miller MA; Lavine CL; Klas SD; Pfeffer LM; Whitt MA
    Protein Expr Purif; 2004 Jan; 33(1):92-103. PubMed ID: 14680966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a consensus mutation in M protein of vesicular stomatitis virus from persistently infected cells that affects inhibition of host-directed gene expression.
    Ahmed M; Lyles DS
    Virology; 1997 Oct; 237(2):378-88. PubMed ID: 9356348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vesicular stomatitis virus mRNA and inhibition of translation of cellular mRNA--is there a P function in vesicular stomatitis virus?
    Lodish HF; Porter M
    J Virol; 1981 May; 38(2):504-17. PubMed ID: 6264124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of host RNA polymerase II-dependent transcription by vesicular stomatitis virus results from inactivation of TFIID.
    Yuan H; Yoza BK; Lyles DS
    Virology; 1998 Nov; 251(2):383-92. PubMed ID: 9837802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. the influence of the host cell on the inhibition of virus protein synthesis in cells double infected with vesicular stomatitis virus and mengovirus.
    Otto MJ; Lucas-Lenard J
    J Gen Virol; 1980 Oct; 50(2):293-307. PubMed ID: 6257824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VSV replication in neurons is inhibited by type I IFN at multiple stages of infection.
    Trottier MD; Palian BM; Reiss CS
    Virology; 2005 Mar; 333(2):215-25. PubMed ID: 15721356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Release of low infectivity vesicular stomatitis virus particles from tunicamycin-treated cells.
    Maheshwari RK; Singh VK; Husain MM; Friedman RM; Mohanty SB
    J Exp Pathol; 1985; 2(3):149-63. PubMed ID: 3023584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitivity of prostate tumors to wild type and M protein mutant vesicular stomatitis viruses.
    Ahmed M; Cramer SD; Lyles DS
    Virology; 2004 Dec; 330(1):34-49. PubMed ID: 15527832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression of a vesicular stomatitis virus infection in primary lymphocytes is restricted at multiple levels during B cell activation.
    Schmidt MR; Gravel KA; Woodland RT
    J Immunol; 1995 Sep; 155(5):2533-44. PubMed ID: 7650383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolution of vesicular stomatitis virus in athymic nude mice: mutations associated with natural killer cell selection.
    Vandepol SB; Holland JJ
    J Gen Virol; 1986 Mar; 67 ( Pt 3)():441-51. PubMed ID: 3005478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuation of recombinant vesicular stomatitis viruses encoding mutant glycoproteins demonstrate a critical role for maintaining a high pH threshold for membrane fusion in viral fitness.
    Fredericksen BL; Whitt MA
    Virology; 1998 Jan; 240(2):349-58. PubMed ID: 9454708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potency of wild-type and temperature-sensitive vesicular stomatitis virus matrix protein in the inhibition of host-directed gene expression.
    Lyles DS; McKenzie MO; Ahmed M; Woolwine SC
    Virology; 1996 Nov; 225(1):172-80. PubMed ID: 8918544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of vesicular stomatitis virus M protein mutants in cell rounding is correlated with the ability to inhibit host gene expression and is not correlated with virus assembly function.
    Lyles DS; McKenzie MO
    Virology; 1997 Mar; 229(1):77-89. PubMed ID: 9123880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assembly functions of vesicular stomatitis virus matrix protein are not disrupted by mutations at major sites of phosphorylation.
    Kaptur PE; McKenzie MO; Wertz GW; Lyles DS
    Virology; 1995 Feb; 206(2):894-903. PubMed ID: 7856102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix protein of VSV New Jersey serotype containing methionine to arginine substitutions at positions 48 and 51 allows near-normal host cell gene expression.
    Kim GN; Kang CY
    Virology; 2007 Jan; 357(1):41-53. PubMed ID: 16962155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translation of mRNAs from vesicular stomatitis virus and vaccinia virus is differentially blocked in cells with depletion of eIF4GI and/or eIF4GII.
    Welnowska E; Castelló A; Moral P; Carrasco L
    J Mol Biol; 2009 Dec; 394(3):506-21. PubMed ID: 19769989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of additional genes in a vector derived from a minimal RNA virus.
    Rolls MM; Haglund K; Rose JK
    Virology; 1996 Apr; 218(2):406-11. PubMed ID: 8610469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistence of vesicular stomatitis virus in cloned interleukin-2-dependent natural killer cell lines.
    Rosenthal KL; Zinkernagel RM; Hengartner H; Groscurth P; Dennert G; Takayesu D; Prevec L
    J Virol; 1986 Nov; 60(2):539-47. PubMed ID: 3021987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the human MxA protein is associated with hyperphosphorylation of VSV P protein in human neural Cells.
    Schuster A; Johnston IC; Das T; Banerjee AK; Pavlovic J; ter Meulen V; Schneider-Schaulies S
    Virology; 1996 Jun; 220(1):241-5. PubMed ID: 8659121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.